The model system transforming pulmonary research: an interview with Darrell Kotton

In this interview, Darrell Kotton, Director of the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Centre (MA, USA) discusses the use of induced pluripotent stem cells (iPSC) technology in human cell biology, with a particular focus on pulmonary research. Kotton explores the benefits of using iPSC technology in research, discusses the regulatory challenges that limit the broader application of iPSC-based therapies and examines the unique complexities of developing targeted therapies for diseases of the lungs – one of the most resilient and protected organs. Please introduce yourself and tell us a little bit about what your...